Skip to main content

Month: January 2024

Northway Financial, Inc. Announces 2023 Earnings and Declares Semi-Annual Dividend

NORTH CONWAY, N.H., Jan. 26, 2024 (GLOBE NEWSWIRE) — Northway Financial, Inc. (the “Company”) (OTCQB: NWYF), the parent company of Northway Bank (the “Bank”), today reported net income for the year ended December 31, 2023 of $5.8 million, or $2.10 per basic common share, compared to $2.7 million, or $0.97 per basic common share for the year ended December 31, 2022. The Board of Directors declared a semi-annual cash dividend of $0.35 per common share, payable on February 12, 2024, to common stockholders of record on February 5, 2024. President and CEO William J. Woodward commented: “This past year was a difficult year for us as we dealt with the Federal Reserve’s interest rate hikes, which started in March 2022 and continued into 2023. These 11 rate increases significantly impacted our deposit and loan balances. We experienced a...

Continue reading

First Hawaiian, Inc. Reports Fourth Quarter 2023 Financial Results and Declares Dividend

HONOLULU, Hawaii, Jan. 26, 2024 (GLOBE NEWSWIRE) — First Hawaiian, Inc. (NASDAQ:FHB), (“First Hawaiian” or the “Company”) today reported financial results for its quarter ended December 31, 2023. “I’m happy to report that we finished 2023 with a strong fourth quarter. Our loan balances were stable, we grew consumer and commercial deposits, and credit quality remained excellent,” said Bob Harrison, Chairman, President, and CEO. “During the fourth quarter we also took action to strengthen our balance sheet and increase our future earnings power by selling low-yielding securities. We intend to use the proceeds to reduce high-cost deposits which will increase our net interest margin and net interest income in 2024.” On January 24, 2024, the Company’s Board of Directors declared a quarterly cash dividend of $0.26 per share. The dividend...

Continue reading

South Plains Financial, Inc. Reports Fourth Quarter and Year-End 2023 Financial Results

LUBBOCK, Texas, Jan. 26, 2024 (GLOBE NEWSWIRE) — South Plains Financial, Inc. (NASDAQ:SPFI) (“South Plains” or the “Company”), the parent company of City Bank (“City Bank” or the “Bank”), today reported its financial results for the quarter and year ended December 31, 2023. Fourth Quarter 2023 HighlightsNet income for the fourth quarter of 2023 was $10.3 million, compared to $13.5 million for the third quarter of 2023 and $12.6 million for the fourth quarter of 2022. Diluted earnings per share for the fourth quarter of 2023 was $0.61, compared to $0.78 for the third quarter of 2023 and $0.71 for the fourth quarter of 2022. Average cost of deposits for the fourth quarter of 2023 increased to 224 basis points, compared to 207 basis points for the third quarter of 2023 and 97 basis points for the fourth quarter of 2022. Net interest...

Continue reading

Program for the publication of Yara International ASA fourth quarter results 2023

Oslo, 26 January 2024: Yara International ASA fourth quarter 2023 results will be published on Friday, 9 February 2024 at 08:00 CET. An online presentation will be held at 12:00 CET. The presentation will be held in English. The report, presentation and webcast will be available at the above mentioned times at:https://yara.com/investor-relations/latest-quarterly-report/ There will also be a conference call at 13:00 CET the same day with an opportunity to ask questions to Yara’s management. Please use the link to register for this session:https://registrations.events/direct/Q4I96716 Registered conference call participants will receive a confirmation with a full list of available international dial-in numbers and a unique passcode. If you do not see the email in a few minutes after completed registration, please check the “junk mail” folder...

Continue reading

Dime Community Bancshares, Inc. Reports Fourth Quarter 2023 Results

Total Deposits Grow By Over $276 Million on a Year-Over-Year Basis; Growth Driven By Deposit Gathering Group Hires Capital Ratios Continue to Increase and Asset Quality Remains Stable HAUPPAUGE, N.Y., Jan. 26, 2024 (GLOBE NEWSWIRE) — Dime Community Bancshares, Inc. (NASDAQ: DCOM) (the “Company” or “Dime”), the parent company of Dime Community Bank (the “Bank”), today reported net income available to common stockholders of $88.8 million for the year ended December 31, 2023, or $2.29 per diluted common share, compared to net income available to common stockholders of $145.3 million for the year ended December 31, 2022, or $3.73 per diluted common share. Stuart H. Lubow, President and Chief Executive Officer (“CEO”) of the Company, stated, “Our fourth quarter results were marked by a continued stabilization in our non-interest-bearing...

Continue reading

DraftKings to Release Fourth Quarter and Full Year 2023 Results on February 15, 2024 and Host Conference Call on February 16, 2024

BOSTON, Jan. 26, 2024 (GLOBE NEWSWIRE) — DraftKings Inc. (Nasdaq: DKNG) (the “Company” or “DraftKings”) today announced that it will release its fourth quarter and full year 2023 results after the close of market trading on Thursday, February 15, 2024. DraftKings will host a conference call and audio webcast the following morning, Friday, February 16, 2024, at 8:30 a.m. ET, during which management will discuss the Company’s results and provide commentary on business performance. To listen to the audio webcast and live Q&A, please visit DraftKings’ investor relations website at investors.draftkings.com. The audio webcast will be available on the Company’s investor relations website until 11:59 p.m. ET on March 31, 2024. About DraftKingsDraftKings Inc. is a digital sports entertainment and gaming company created to be the Ultimate...

Continue reading

CRB-701 (SYS6002) A Next Generation Nectin-4 Targeting Antibody Drug Conjugate Demonstrates Encouraging Safety and Efficacy in Patients with Nectin-4 Positive Tumors in First-In-Human Study Presented at ASCO-GU 2024

Q3W schedule of CRB-701 (SYS6002) demonstrates a 43% ORR and 71% DCR at predicted therapeutically relevant doses All assessable nectin-4 positive study participants with mUC and cervical cancer treated at or above this dose demonstrated some level of disease control No dose limiting toxicities (DLTs) have been observed to-date up to 3.6 mg/kg (cohort 6) with further escalation at 4.5 mg/kg ongoing No cases of peripheral neuropathy or skin rash have been observed to date Cohort 6 is the first cohort selected for dose expansionNORWOOD, Mass., Jan. 26, 2024 (GLOBE NEWSWIRE) — Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus” or the “Company”), today announced that data from the first-in-human clinical study of CRB-701 (SYS6002) is being presented as a poster by the Company’s development partner CSPC Pharmaceutical...

Continue reading

BullFrog AI Strengthens Scientific Advisory Board with the Addition of Dr. Gwenn Smith and Dr. Jeremiah Wala

GAITHERSBURG, Md., Jan. 26, 2024 (GLOBE NEWSWIRE) — BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) (“BullFrog AI” or the “Company”), a technology-enabled drug development company using artificial intelligence (AI) and machine learning to enable the successful development of pharmaceuticals and biologics, today announced the appointment of two distinguished scientific advisors to its advisory board: Gwenn S. Smith, PhD, and Jeremiah Wala, MD, PhD. “We are thrilled to welcome Dr. Smith and Dr. Wala to our advisory board,” said Vin Singh, CEO of BullFrog AI. “Their remarkable achievements and deep knowledge in their respective fields will be invaluable as we continue to push the boundaries of AI in biotechnology, and their insights will be instrumental in guiding our mission to develop breakthrough therapies...

Continue reading

AppTech Payments Announces Strategic Partnership with First Inning Ventures to Expand Commerse™ Suite in the International and Domestic Sports Market

Strategic Collaboration Set to Revolutionize Fintech Integration in the Sports Industry CARLSBAD, Calif., Jan. 26, 2024 (GLOBE NEWSWIRE) — AppTech Payments Corp. (Nasdaq: APCX) (“AppTech” or the “Company”), a pioneering Fintech company powering frictionless commerce between business-to-business and business-to-consumer, announces a strategic partnership with First Inning Ventures (FIV), an international sports marketing and consulting agency. Luke D’Angelo, AppTech CEO, commented, “The collaboration with First Inning aligns seamlessly with our vision to drive new revenue within addressable markets ripe for transformative growth. We look forward to working closely with FIV to leverage their extensive relationship infrastructure to help scale the user base of our Specialty Payments platform while building long-term shareholder value.” FIV...

Continue reading

Apellis Announces Negative CHMP Opinion for Pegcetacoplan for GA in the European Union and Plans to Seek Re-Examination of Application

WALTHAM, Mass., Jan. 26, 2024 (GLOBE NEWSWIRE) — Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has adopted a negative opinion on the marketing authorization application (MAA) of intravitreal pegcetacoplan for the treatment of geographic atrophy (GA) secondary to age-related macular degeneration (AMD). As previously announced, this opinion was expected based on a negative trend vote following an oral explanation meeting in December 2023. Apellis plans to seek immediate re-examination of its application. “We are very disappointed in this outcome on behalf of the millions of Europeans with GA who currently have no treatment options for this irreversible form of blindness,” said Jeffrey Eisele, Ph.D., chief development officer,...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.